Advertisement
Product › Details
Eklira®
Next higher product group | aclidinium | |
Status | 2012-09-30 sales start | |
Status | 2014-11-01 sales start | |
Organisation | Almirall (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for bronchospasmolytics & asthma drugs_o
- [1] AstraZeneca plc. (11/1/21). "Press Release: AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma"....
- [2] Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford....
- [3] GlaxoSmithKline plc. (7/24/17). "Press Release: GSK Submits US Regulatory Filing of Arnuity Ellipta in Children with Asthma"....
- [4] AstraZeneca plc. (3/17/17). "Press Release: AstraZeneca and Circassia Enter Strategic Collaboration in Respiratory Disease"....
- [5] Boehringer Ingelheim. (2/16/17). "Press Release: US FDA Expands Approval of Tiotropium Respimat for Maintenance Treatment of Asthma in Children". Ingelheim....
- [6] AstraZeneca plc. (1/30/17). "Press Release: US FDA Approves Symbicort (budesonide/formoterol) for the Treatment of Asthma in Paediatric Patients"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top